Balanced news tone
News Sentiment
PFE sentiment intelligence
Pfizer Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-0.8% over one week, -6.3% over four weeks, trend inactive, and near fair-value range.
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Pfizer (PFE)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV) and Pfizer (PFE)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 09:23
- Source
- The Globe and Mail
Pfizer (PFE) Could Be 16% Undervalued On New FDA Approval In Bladder Cancer
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 17 Jul 2026 07:28
- Source
- simplywall.st
Pfizer (PFE) Stock Looks Fairly Priced With Pipeline Risks In View
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 16 Jul 2026 17:12
- Source
- Market source
Pfizer Stock Below 50-Day and 200-Day SMA: Buy the Dip or Exit Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 16:26
- Source
- The Globe and Mail
Pfizer Abrysvo by Pfizer Inc. - RSV vaccine targets seniors and pregnant women
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 06:34
- Source
- ad-hoc-news.de
Pfizer (NYSE:PFE) Faces New Patent Claim After $96 Billion in COVID Vaccine Revenue
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 21:47
- Source
- TechStock²
Pfizer (PFE) Stock Looks Fully Priced After Its 21% Slump
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Jul 2026 17:38
- Source
- simplywall.st
Here's What to Expect From Pfizer's Next Earnings Report
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 14:02
- Source
- Market source
Pfizer Abrysvo by Pfizer Inc. - RSV vaccine targets older adults and pregnancy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 05:10
- Source
- ad-hoc-news.de
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Pfizer's CEO Says His Company Has a "Very Big Balance Sheet" to Do Deals. Here's the Perfect Next Acquisition Target for the Pharma Giant.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 07:00
- Source
- The Motley Fool
Pfizer vs Verizon Communications: Which High-Yielding Dividend Stock Is the Better Buy?
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 01 Jul 2026 07:00
- Source
- Market source
Is Pfizer (PFE) Stock Undervalued Despite Mixed Oncology Progress?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Is Pfizer Inc. (PFE) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Market source
Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 27 Jun 2026 07:00
- Source
- Market source
Pfizer Declares Third-Quarter 2026 Dividend
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 24 Jun 2026 07:00
- Source
- Business Wire
Pfizer (PFE) Is Down 7.3% After Mixed Oncology Updates Reshape Its Long-Term Pipeline Narrative
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Pfizer CEO warns German investment at risk over drug pricing policies
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Reuters
Pfizer Inc stock (US7170811035): focus on oncology pipeline after Jefferies 2026 appearance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- ad-hoc-news.de
Pfizer Inc. stock (US7170811035): shares steady as investors digest oncology deal news and recent ea
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 03 Jun 2026 07:00
- Source
- ad-hoc-news.de
If You Invested $1,000 in Pfizer (PFE)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Mar 2026 02:02
- Source
- Stock Titan
Is There 25% Downside For Pfizer Stock?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Feb 2026 08:00
- Source
- Forbes
Pfizer (PFE) Q4 2025 Earnings Preview: Revenue Decline Expected - News and Statistics
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 01 Feb 2026 08:00
- Source
- IndexBox
Pfizer vs. Merck Stock And JNJ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jan 2026 08:00
- Source
- Forbes
Pfizer Cuts BioNTech Stake by More Than Half
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 14 Nov 2025 08:00
- Source
- Market source
Pfizer slashes stake in COVID vaccine partner BioNTech
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 13 Nov 2025 08:00
- Source
- Reuters
After A 30% Fall In A Year, Is Pfizer Stock A Better Pick Over Merck?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 02 Apr 2024 07:00
- Source
- Forbes
Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2023 07:00
- Source
- Reuters
Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccine
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Aug 2022 07:00
- Source
- Reuters